News
FIGEAC AÉRO: 9M 2024/25 REVENUE: €303.0 MILLION, +9.6% - PILOT 28 TARGETS REVISED UPWARDS
EQS-News: Abivax Publishes 2025 Financial Calendar
Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2024
Bureau Veritas - Statement
In a statement issued on January 15th, 2025, Bureau Veritas and SGS communicated that they had engaged in discussions with regards to a potential business combination.
Today, Bureau Veritas
EQS-News: Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
GenSight Biologics Reports End-of-Year Cash Position and Provides Business Update
Regulatory News:
GenSight Biologics ("GenSight Biologics" or the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing
Eutelsat Partners with NIGCOMSAT to Launch LEO Satellite Services in Nigeria
Regulatory News:
Eutelsat Group (ISIN: FR0010221234 - Euronext Paris / London Stock Exchange: ETL), a global leader in satellite communications and Nigerian Communications Satellite Limited
Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan
Regulatory News:
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic
Medidata Expands Leadership Team to Drive Patient-Centered and Customer-Focused Innovation
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has named Alicia Staley as chief patient officer and senior vice president
Medidata Expands Leadership Team to Drive Patient-Centered and Customer-Focused Innovation
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has named Alicia Staley as chief patient officer and senior vice president
Verimatrix gibt Einführung der Over-the-Air-CAS-Nachrüstlösung DVB ReAccess bekannt
Verimatrix, (Euronext Paris: VMX, FR0010291245), das führende Unternehmen im Bereich der modernen vernetzten Welt mit menschenzentrierter Sicherheit, gab heute die allgemeine Verfügbarkeit seiner
Bureau Veritas: Statement
Following recent media commentary, Bureau Veritas indicates that it is in discussions with SGS regarding a potential business combination. There can be no assurance that these discussions will
GenSight Biologics Announces Publication of 5-Year Outcomes for Patients Treated Unilaterally with LUMEVOQ® Gene Therapy
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal
Verimatrix Announces Release of DVB ReAccess Over-the-Air CAS Retrofit Solution
Regulatory News:
Verimatrix, (Euronext Paris: VMX, FR0010291245), the leader in powering the modern connected world with people-centered security, today announced general availability of its new
EQS-News: Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
FIGEAC AÉRO: 28 JANUARY 2025: 3RD QUARTER REVENUE RELEASE AND UPDATE ON THE PILOT 28 PLAN
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA, 2024 DECEMBRE 31th
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Eutelsat Statement on OneWeb Temporary Outage
Regulatory News:
Eutelsat (ISIN: FR0010221234 - Euronext Paris / London Stock Exchange: ETL), experienced a temporary, 48-hour outage on its OneWeb Low Orbit service, commencing on 31st December
EQS-News: Abivax Announces a Change to the Composition of its Board of Directors
ClinChoice verlängert 13-jährige Partnerschaft mit Medidata – Ergänzung von Clinical Data Studio zur Optimierung des Datenmanagements und Stärkung der Fähigkeiten im Bereich klinischer Studien
Medidata, eine Marke von Dassault Systèmes und führender Anbieter von Lösungen für klinische Studien in der Life-Science-Branche, erneuert seine langjährige Unternehmenspartnerschaft mit dem
ClinChoice verlängert 13-jährige Partnerschaft mit Medidata – Ergänzung von Clinical Data Studio zur Optimierung des Datenmanagements und Stärkung der Fähigkeiten im Bereich klinischer Studien
Medidata, eine Marke von Dassault Systèmes und führender Anbieter von Lösungen für klinische Studien in der Life-Science-Branche, erneuert seine langjährige Unternehmenspartnerschaft mit dem